RecruitingPhase 1NCT05865470

Age-dependent Effects of Smoked and Oral Delta-9-THC

Sex- and AGE-dependent Effects of Smoked and Oral Delta-9-THC


Sponsor

University of California, Los Angeles

Enrollment

103 participants

Start Date

Apr 30, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study will assess the age-dependent effects of smoked and oral THC on abuse liability, intoxication, analgesia and impairment as a function of age.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Cannabis, a drug called Dronabinol, and others for people with abuse, drug, intoxication; cannabinoids, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCannabis

smoked cannabis

DRUGDronabinol

Oral delta-9-THC

DRUGSmoked Placebo

Placebo Cannabis

DRUGOral Placebo

Oral Placebo


Locations(1)

UCLA Center for Cannabis and Cannabinoids

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05865470


Related Trials